| Nisarg N Shah, MD | |
|
1105 Central Expy N, Allen, TX 75013-6103 | |
| (972) 747-6552 | |
| Not Available |
| Full Name | Nisarg N Shah |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1105 Central Expy N, Allen, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467494344 | NPI | - | NPPES |
| 145197302 | Medicaid | TX | |
| 0006HX | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | L1196 (Texas) | Primary |
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Healthcare-associated infections (HAIs) are less likely to occur in favorable critical care work environments, according to a study of more than 3,200 nurses in the November issue of American Journal of Critical Care (AJCC).
Noting that an estimated $2 billion was spent on the U.S. presidential campaigns, Peter Hotez, president of the Sabin Vaccine Institute and founding dean of the National School of Tropical Medicine at the Baylor College of Medicine, writes in the Huffington Post "Healthy Living" blog, "Many of us in the global health community can only look upon that $2 billion figure in awe because of the potential for those dollars to be repurposed to immediately and dramatically improve the lives of the poorest people who suffer from disease."
New research has shed light on the origins of spinocerebellar ataxia type 7 (SCA7) and demonstrates effective new therapeutic pathways for SCA7 and the more than 40 other types of spinocerebellar ataxia.
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Absorption Systems, a leader in novel test systems for drug transporters, announces a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein).
› Verified 1 days ago
| Entity Name | Texas Physician Resources, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639413289 PECOS PAC ID: 7012161375 Enrollment ID: O20130214000159 |
News Archive
Healthcare-associated infections (HAIs) are less likely to occur in favorable critical care work environments, according to a study of more than 3,200 nurses in the November issue of American Journal of Critical Care (AJCC).
Noting that an estimated $2 billion was spent on the U.S. presidential campaigns, Peter Hotez, president of the Sabin Vaccine Institute and founding dean of the National School of Tropical Medicine at the Baylor College of Medicine, writes in the Huffington Post "Healthy Living" blog, "Many of us in the global health community can only look upon that $2 billion figure in awe because of the potential for those dollars to be repurposed to immediately and dramatically improve the lives of the poorest people who suffer from disease."
New research has shed light on the origins of spinocerebellar ataxia type 7 (SCA7) and demonstrates effective new therapeutic pathways for SCA7 and the more than 40 other types of spinocerebellar ataxia.
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Absorption Systems, a leader in novel test systems for drug transporters, announces a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein).
› Verified 1 days ago
| Entity Name | Texas Medicine Resources, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376581900 PECOS PAC ID: 5890688212 Enrollment ID: O20130702000785 |
News Archive
Healthcare-associated infections (HAIs) are less likely to occur in favorable critical care work environments, according to a study of more than 3,200 nurses in the November issue of American Journal of Critical Care (AJCC).
Noting that an estimated $2 billion was spent on the U.S. presidential campaigns, Peter Hotez, president of the Sabin Vaccine Institute and founding dean of the National School of Tropical Medicine at the Baylor College of Medicine, writes in the Huffington Post "Healthy Living" blog, "Many of us in the global health community can only look upon that $2 billion figure in awe because of the potential for those dollars to be repurposed to immediately and dramatically improve the lives of the poorest people who suffer from disease."
New research has shed light on the origins of spinocerebellar ataxia type 7 (SCA7) and demonstrates effective new therapeutic pathways for SCA7 and the more than 40 other types of spinocerebellar ataxia.
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Absorption Systems, a leader in novel test systems for drug transporters, announces a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein).
› Verified 1 days ago
| Entity Name | Pediatric Emergency Medicine Group, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629448535 PECOS PAC ID: 9931409943 Enrollment ID: O20151124000478 |
News Archive
Healthcare-associated infections (HAIs) are less likely to occur in favorable critical care work environments, according to a study of more than 3,200 nurses in the November issue of American Journal of Critical Care (AJCC).
Noting that an estimated $2 billion was spent on the U.S. presidential campaigns, Peter Hotez, president of the Sabin Vaccine Institute and founding dean of the National School of Tropical Medicine at the Baylor College of Medicine, writes in the Huffington Post "Healthy Living" blog, "Many of us in the global health community can only look upon that $2 billion figure in awe because of the potential for those dollars to be repurposed to immediately and dramatically improve the lives of the poorest people who suffer from disease."
New research has shed light on the origins of spinocerebellar ataxia type 7 (SCA7) and demonstrates effective new therapeutic pathways for SCA7 and the more than 40 other types of spinocerebellar ataxia.
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Absorption Systems, a leader in novel test systems for drug transporters, announces a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nisarg N Shah, MD Po Box 8549, Fort Worth, TX 76124-0549 Ph: (817) 451-4208 | Nisarg N Shah, MD 1105 Central Expy N, Allen, TX 75013-6103 Ph: (972) 747-6552 |
News Archive
Healthcare-associated infections (HAIs) are less likely to occur in favorable critical care work environments, according to a study of more than 3,200 nurses in the November issue of American Journal of Critical Care (AJCC).
Noting that an estimated $2 billion was spent on the U.S. presidential campaigns, Peter Hotez, president of the Sabin Vaccine Institute and founding dean of the National School of Tropical Medicine at the Baylor College of Medicine, writes in the Huffington Post "Healthy Living" blog, "Many of us in the global health community can only look upon that $2 billion figure in awe because of the potential for those dollars to be repurposed to immediately and dramatically improve the lives of the poorest people who suffer from disease."
New research has shed light on the origins of spinocerebellar ataxia type 7 (SCA7) and demonstrates effective new therapeutic pathways for SCA7 and the more than 40 other types of spinocerebellar ataxia.
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Absorption Systems, a leader in novel test systems for drug transporters, announces a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein).
› Verified 1 days ago
Mrs. Chay Shalise Nersesian, M.ED, ATC, LAT, CES Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Rivercrest Blvd, Allen, TX 75002 Phone: 972-727-4037 Fax: 972-727-7103 | |
Marian Bednar, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 1105 Central Expy N, Allen, TX 75013 Phone: 972-747-6552 | |
Stephan M Kramer, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1105 Central Expy N, Allen, TX 75013 Phone: 972-747-6552 | |
Dr. Joseph Starr Fagner, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 304 W Boyd Dr Unit 915, Allen, TX 75013 Phone: 469-831-1839 | |
Jonathan Franklin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1105 Central Expy N, Allen, TX 75013 Phone: 972-747-6552 | |
Eden T Yang, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 1105 Central Expy N, Allen, TX 75013 Phone: 972-747-6552 |